Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

Data as of Jan 27
 -0.02 / -1.48%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues13.5M15.2M21.7M22.4M
Operating ExpensesGross Income6.2M5.1M9.1M9.3M
Total Operating Expenses48.2M57.3M50.0M58.1M
Non-Operating ExpensesOperating Income-34.7M-42.1M-28.4M-35.7M
Extraordinary Charge0.000.00-1.7M0.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-34.2M-42.1M-29.8M-35.4M
Preferred Dividend0.000.000.00-401.0K
Net Income-34.2M-42.1M-29.8M-35.4M
Shares To Calculate EPSShares To Calculate EPS60.9M83.6M120.4M161.6M
Shares To Calculate EPS Diluted60.9M83.6M120.4M161.6M
Earnings Per ShareEPS-$0.56-$0.50-$0.25-$0.22
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.